Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform 
NOSTER Research: Gut bacteria derived metabolites offer alternative treatment for fatty liver disease 
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US 
Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy USA – English  
Everest Medicines Announces China NMPA’s Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients USA – English  
Agilus Diagnostics launches advanced laboratory in Bongaigaon
Agilus Diagnostics, a subsidiary of Fortis Healthcare Limited., today announced the launch of a new laboratory in Bongaigaon, Assam. The...
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces the publication of...
Bracco Announces Long-Term Strategic Partnership with ulrich medical for Syringeless Magnetic Resonance Injectors
Bracco, a global leader in diagnostic imaging, and ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing...
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the...
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
Apotex Corp. announced today the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the...
Glassbeam Awarded FedRAMP® ‘In-Process’ Status for its SaaS analytics solution for connected medical systems
Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced it has achieved the 'In...
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of...
Vaccine Partner Valneva receives FDA approval for the World’s first chikungunya vaccine using Albumedix’ Recombumin®
The FDA on 10th November 2023 announced the approval of IXCHIQ®, Valneva's vaccine against the chikungunya virus. Notably, this is the first vaccine...
WELL Health Announces Launch of WELL AI Inbox Admin: A Revolutionary AI-Powered Solution for Clinic Inbox Management
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health...
Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases,...
